Non-smoking woman with adenocarcinoma of the lung, IV stage with ROS1 mutation and acquired thrombophilia
Open Access
- 4 August 2021
- journal article
- Published by Heighten Science Publications Corporation in Journal of Pulmonology and Respiratory Research
- Vol. 5 (1), 064-072
- https://doi.org/10.29328/journal.jprr.1001027
Abstract
Despite the fact, that lung cancer is more common among older smoking men, however it may also develop among young women without a smoking anamnesis. We report here a history of a non-smoking woman, 40 years old, with a diagnosis of lung adenocarcinoma at IV stage. Despite the fact, the woman received three lines of palliative chemotherapy, the disease progressed. After the sample of the tumor was tested by genetic approach, ROS1 mutation was detected, and the patient was treated with a ROS1 inhibitor, Crizotinib. Sharp improvement was observed already after the first week of treatment. After one-month adenocarcinoma shrink, and specific supraclavicular lymph nodes disappeared. Unfortunately, due to problems with financing the treatment was stopped, after what the disease began to progress rapidly, and the patient died after a month due to brain metastasis. This case is noteworthy also because the patient was first diagnosed a thrombophilia with thrombi present in deep calf veins, left heart ventricle and lungs Adenocarcinoma was discovered occasionally when during video-assisted thoracoscopic surgery biopsy specimen was taken from suspicious mass in the lower lobe of the right lung. This story reminds us that lung carcinoma may start with a paraneoplastic syndrome, like thrombophilia as in this case and finding of adenocarcinoma of the lung in young, non-smoking persons is indicative for possible ROS1 gene mutation. In such cases early treatment with ROS1 protein-tyrosine kinase inhibitors should be started as soon as possible.Keywords
This publication has 21 references indexed in Scilit:
- ROS1 mutation and treatment with crizotinib in a 30‐year old Caucasian woman with stage IV non‐small cell lung cancer/adenocarcinoma and complete remissionThoracic Cancer, 2014
- ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung AdenocarcinomasThe American Journal of Surgical Pathology, 2013
- Molecular Pathways: ROS1 Fusion Proteins in CancerClinical Cancer Research, 2013
- Epidemiology of Lung CancerSeminars in Interventional Radiology, 2013
- Lung cancer in womenLung Cancer: Targets and Therapy, 2012
- The Oncogenic Lung Cancer Fusion Kinase CD74-ROS Activates a Novel Invasiveness Pathway through E-Syt1 PhosphorylationCancer Research, 2012
- ROS1 Rearrangements Define a Unique Molecular Class of Lung CancersYearbook of Oncology, 2012
- Genetic Link Between Cancer and ThrombosisJournal of Clinical Oncology, 2009
- Hipercoagulabilidade e câncer de pulmãoJornal Brasileiro de Pneumologia, 2008
- Pathology of Lung CancerPublished by Springer Science and Business Media LLC ,2004